Literature DB >> 19675265

Intensive glycemic control: implications of the accord, advance, and VADT trials for family physicians.

Gauranga Chandra Dhar1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19675265      PMCID： PMC2726096     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  6 in total

1.  Redefining quality--implications of recent clinical trials.

Authors:  Harlan M Krumholz; Thomas H Lee
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

2.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

3.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

4.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

5.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

6.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  6 in total
  4 in total

1.  Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling.

Authors:  Mostafa M Elgebaly; Roshini Prakash; Weiguo Li; Safia Ogbi; Maribeth H Johnson; Erin M Mezzetti; Susan C Fagan; Adviye Ergul
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

Review 2.  Continuous Glucose Monitoring Systems: A Review.

Authors:  Sandeep Kumar Vashist
Journal:  Diagnostics (Basel)       Date:  2013-10-29

3.  Safety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve study.

Authors:  Issam Hajjaji; Siddharth Shah; Yuxiu Li; Vinay Prusty; Youcef Benabbas; Philip D Home
Journal:  Diabetes Ther       Date:  2014-01-30       Impact factor: 2.945

4.  Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11).

Authors:  Aslam Amod; John B Buse; Darren K McGuire; Thomas R Pieber; Rodica Pop-Busui; Richard E Pratley; Bernard Zinman; Marco Bo Hansen; Ting Jia; Thomas Mark; Neil R Poulter
Journal:  Diabetes Ther       Date:  2019-10-30       Impact factor: 2.945
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.